David J Peace

David J Peace

UNVERIFIED PROFILE

Are you David J Peace?   Register this Author

Register author
David J Peace

David J Peace

Publications by authors named "David J Peace"

Are you David J Peace?   Register this Author

11Publications

258Reads

34Profile Views

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.

Biol Blood Marrow Transplant 2014 Dec 16;20(12):2034-41. Epub 2014 Sep 16.

Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.09.005DOI Listing
December 2014

Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue (PSA146-154).

Clin Dev Immunol 2010 5;2010:473453. Epub 2011 Jan 5.

Section of Hematology and Oncology, Department of Medicine, College of Medicine Research Building, University of Illinois at Chicago, 909 South Wolcott Avenue, Chicago, IL 60612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/473453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022181PMC
May 2011

An introduction to foundation and industry-sponsored research: practical and ethical considerations.

Hematology Am Soc Hematol Educ Program 2007 :498-503

Section of Hematology/Oncology, Clinical Science Building, Ste 820 (MC787), 840 S. Wood Street, Chicago, IL 60612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2007.1.498DOI Listing
July 2009

Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide.

Cancer Immunol Immunother 2006 Sep 10;55(9):1033-42. Epub 2005 Nov 10.

Department of Medicine, Section of Hematology/Oncology, University of Illinois, Room 3150, Molecular Biology Research Building, 900 South Ashland Avenue, Chicago, IL 60607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0090-xDOI Listing
September 2006

Distinct cytokine patterns exist in peripheral blood mononuclear cell cultures of patients with prostate cancer.

Clin Immunol 2005 Oct;117(1):94-9

Department of Medicine, Section of Hematology and Oncology (M/C 734), University of Illinois, Molecular Biology Research Building, Chicago, 60607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2005.06.011DOI Listing
October 2005

Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo.

Cancer Gene Ther 2005 Jun;12(6):540-51

Division of Experimental Therapeutics, Ontario Cancer Institute, Toronto, Ontario, Canada M5G 2M1.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/7700810
Publisher Site
http://dx.doi.org/10.1038/sj.cgt.7700810DOI Listing
June 2005

Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer.

Cancer Immunol Immunother 2002 Jul 24;51(5):263-70. Epub 2002 Apr 24.

Section of Hematology/Oncology (M/C 734), Room 3150, Molecular Biology Research Building, 900 S. Ashland Avenue, The University of Illinois at Chicago, Chicago, IL 60607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-002-0281-7DOI Listing
July 2002